Treatment Refractory: 11147 Clinical Trials, Page 10 of 1115

« First Page «…5 …8 9 10 11 12 …15 20 25 … »Last Page »

Genetically Modified T Cells and Decitabine in Treating Patients With Recurrent or Refractory Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Condition(s):Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal CarcinomaLast Updated:March 15, 2023Active, not recruiting

Phase I Study of Ipilimumab (Anti-CTLA-4) in Children and Adolescents With Treatment-Resistant Cancer

Condition(s):Sarcoma; Wilm’s Tumor; Lymphoma; NeuroblastomaLast Updated:December 17, 2019Completed

Genetically Engineered Cells (NY-ESO-1 TCR Engineered T Cells and HSCs) After Melphalan Conditioning Regimen in Treating Patients With Recurrent or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

Condition(s):Platinum-Resistant Fallopian Tube Carcinoma; Platinum-Resistant Ovarian Carcinoma; Platinum-Resistant Primary Peritoneal Carcinoma; Platinum-Sensitive Fallopian Tube Carcinoma; Platinum-Sensitive Ovarian Carcinoma; Platinum-Sensitive Primary Peritoneal Carcinoma; Recurrent Fallopian Tube Carcinoma; Recurrent Ovarian Carcinoma; Recurrent Primary Peritoneal Carcinoma; Refractory Fallopian Tube Carcinoma; Refractory Ovarian Carcinoma; Refractory Primary Peritoneal CarcinomaLast Updated:July 15, 2022Active, not recruiting

Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NT

Condition(s):Malignant Neoplasm of Breast; Malignant Neoplasms of Digestive Organs; Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System; Malignant Neoplasms of Female Genital Organs; Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites; Malignant Neoplasms of Independent (Primary) Multiple Sites; Malignant Neoplasms of Lip Oral Cavity and Pharynx; Malignant Neoplasms of Male Genital Organs; Malignant Neoplasms of Mesothelial and Soft Tissue; Malignant Neoplasms of Respiratory and Intrathoracic Organs; Malignant Neoplasms of Thyroid and Other Endocrine Glands; Malignant Neoplasms of Urinary TractLast Updated:February 27, 2023Recruiting

Lamotrigine Augmentation in Resistant Depression

Condition(s):Unipolar DepressionLast Updated:May 13, 2009Completed

Novel Treatment Option for Neuropathic Pain

Condition(s):Neuralgia; Complex Regional Pain SyndromesLast Updated:November 8, 2016Completed

Mesenchymal Stem Cell Therapy for Lung Rejection

Condition(s):Lung Transplant Reject; Bronchiolitis ObliteransLast Updated:October 7, 2021Completed

Study of the Glutaminase Inhibitor CB-839 in Leukemia

Condition(s):Acute Myeloid Leukemia (AML); Acute Lymphocytic Leukemia (ALL)Last Updated:February 9, 2017Completed

Cabozantinib and Panitumumab to Treat KRAS Wild-Type Metastatic Colorectal Cancer

Condition(s):Colorectal CancerLast Updated:February 12, 2021Completed

100

CT Antigen TCR-redirected T Cells for Ovarian Cancer.

Condition(s):Ovarian CancerLast Updated:June 27, 2019Completed

« First Page «…5 …8 9 10 11 12 …15 20 25 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.